These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21965113)

  • 1. Screening assays for epigenetic targets using native histones as substrates.
    Hauser AT; Bissinger EM; Metzger E; Repenning A; Bauer UM; Mai A; Schüle R; Jung M
    J Biomol Screen; 2012 Jan; 17(1):18-26. PubMed ID: 21965113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors.
    Zheng YC; Chang J; Zhang T; Suo FZ; Chen XB; Liu Y; Zhao B; Yu B; Liu HM
    Curr Med Chem; 2017; 24(23):2496-2504. PubMed ID: 28486922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for histone codebreakers.
    Bedford MT
    J Biol Chem; 2018 Aug; 293(35):13766-13767. PubMed ID: 30171150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-based methods for screening writers and readers of histone methyl marks.
    Allali-Hassani A; Wasney GA; Siarheyeva A; Hajian T; Arrowsmith CH; Vedadi M
    J Biomol Screen; 2012 Jan; 17(1):71-84. PubMed ID: 21972038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
    Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
    Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-based assays to support the profiling of small molecules with histone methyltransferase and demethylase modulatory activity.
    Martinez NJ; Simeonov A
    Drug Discov Today Technol; 2015 Nov; 18():9-17. PubMed ID: 26723887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in histone methyltransferases and histone demethylases].
    Wang X; Zhu WG
    Ai Zheng; 2008 Oct; 27(10):1018-25. PubMed ID: 18851779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
    Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
    ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
    Eglen RM; Reisine T
    J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
    Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
    J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous Antibody-Based Activity Assay for Lysine Specific Demethylase 1 (LSD1) on a Histone Peptide Substrate.
    Schmitt ML; Ladwein KI; Carlino L; Schulz-Fincke J; Willmann D; Metzger E; Schilcher P; Imhof A; Schüle R; Sippl W; Jung M
    J Biomol Screen; 2014 Jul; 19(6):973-8. PubMed ID: 24687155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T; Bergner A; Sheppard D; Hafenbradl D
    J Biomol Screen; 2012 Jan; 17(1):85-98. PubMed ID: 21990582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry.
    Hutchinson SE; Leveridge MV; Heathcote ML; Francis P; Williams L; Gee M; Munoz-Muriedas J; Leavens B; Shillings A; Jones E; Homes P; Baddeley S; Chung CW; Bridges A; Argyrou A
    J Biomol Screen; 2012 Jan; 17(1):39-48. PubMed ID: 21859681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro histone demethylase assay.
    Tsukada Y; Nakayama KI
    Cold Spring Harb Protoc; 2010 Oct; 2010(10):pdb.prot5512. PubMed ID: 20889709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.
    Osborne T; Roska RL; Rajski SR; Thompson PR
    J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation.
    Liu Y; Platchek M; Kement B; Bee WT; Truong M; Zeng X; Hung S; Lin H; Morrow D; Kallal LA; Xie Q; Agarwal P; Pope AJ; Wu Z
    Mol Biosyst; 2014 Feb; 10(2):251-7. PubMed ID: 24257700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry insights in the discovery of novel LSD1 inhibitors.
    Wang X; Huang B; Suzuki T; Liu X; Zhan P
    Epigenomics; 2015; 7(8):1379-96. PubMed ID: 26646727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.